Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440924
Max Phase: Preclinical
Molecular Formula: C70H88N14O10
Molecular Weight: 1285.56
Molecule Type: Unknown
Associated Items:
ID: ALA2440924
Max Phase: Preclinical
Molecular Formula: C70H88N14O10
Molecular Weight: 1285.56
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCN(CCNC(=O)CCCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1)CCNC(=O)CCCC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1
Standard InChI: InChI=1S/C70H88N14O10/c71-39-44-84(45-42-74-59(87)27-13-29-61(89)82-69(72)76-40-15-25-57(65(91)78-47-49-31-35-55(85)36-32-49)80-67(93)63(51-17-5-1-6-18-51)52-19-7-2-8-20-52)46-43-75-60(88)28-14-30-62(90)83-70(73)77-41-16-26-58(66(92)79-48-50-33-37-56(86)38-34-50)81-68(94)64(53-21-9-3-10-22-53)54-23-11-4-12-24-54/h1-12,17-24,31-38,57-58,63-64,85-86H,13-16,25-30,39-48,71H2,(H,74,87)(H,75,88)(H,78,91)(H,79,92)(H,80,93)(H,81,94)(H3,72,76,82,89)(H3,73,77,83,90)/t57-,58-/m1/s1
Standard InChI Key: VTTARGWCWRDOCN-YZCGSYMESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1285.56 | Molecular Weight (Monoisotopic): 1284.6808 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Keller M, Kaske M, Holzammer T, Bernhardt G, Buschauer A.. (2013) Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors., 21 (21): [PMID:24074877] [10.1016/j.bmc.2013.08.065] |
Source(1):